Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

NCT07228221 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Open Angle Glaucoma
Pigmentary Glaucoma
Pseudoexfoliation Glaucoma

Interventions

DEVICE: iStent infinite trabecular micro-bypass system model iS3
DRUG: iDose TR (Travoprost intracameral Implant) 75mcg

Sponsor

Jonathon Myers

Collaborators

[object Object]